Whilst these are both obesity-related cancer types, this study did not report the incidence of obesity in its participants, which makes it difficult to conclude how much this effect is due to weight loss
About Wegovy HD (semaglutide) injection 7.2 mg The FDA approval of Wegovy HD is based on the results of the STEP UP program, which included the phase 3 STEP UP clinical trial, which was a 72-week randomized, double-blinded, placebo-controlled and active-controlled superiority trial designed to evaluate the efficacy and safety of once-weekly semaglutide injection 7.2 mg compared to semaglutide injection 2.4 mg and placebo as an adjunct to lifestyle intervention
The primary endpoint was a composite of major cardiovascular events (MACE), including acute myocardial infarction, stroke, and CV failure
You can also view this full study in Truveta Studio
For example, people with autoimmune diseases might have a higher risk of drug allergies